-
Bushe, C, Sobanski, E, Coghill, D, Berggren, L, De Bruyckere, K, Leppämäki, S.
Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database.
CNS Drugs
30(4)
:
317 -334
2016
view publication
-
Inglis, SK, Carucci, S, Garas, P, Häge, A, Banaschewski, T, Buitelaar, JK, Dittmann, RW, Falissard, B, Hollis, C, Kovshoff, H, et al.
Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.
BMJ Open
6(4)
:
e010433
2016
view publication
-
Otero, IH, Banaschewski, T, Nagy, P, Soutullo, CA, Zuddas, A, Caballero, B, Geibel, B, Yan, B, Coghill, DR.
Time-course of treatment-emergent adverse events in a long-term safety study of lisdexamfetamine dimesylate in children and adolescents with ADHD.
European Psychiatry
33(S1)
:
s132
2016
view publication
-
Coghill, D, Hodgkins, P.
Health-related quality of life of children with attention-deficit/hyperactivity disorder versus children with diabetes and healthy controls.
European Child & Adolescent Psychiatry
25(3)
:
261 -271
2016
view publication
-
Nagy, P, Häge, A, Coghill, DR, Caballero, B, Adeyi, B, Anderson, CS, Sikirica, V, Cardo, E.
Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate.
European Child & Adolescent Psychiatry
25(2)
:
141 -149
2016
view publication